Spirometry and diabetes: Implications of reduced lung function

Diabetes Care

Volumn 27, Issue 3, 2004, Pages 837-838

  Kaminsky, David A ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; INSULIN TREATMENT; LUNG FUNCTION; RISK; SPIROMETRY;

DIABETES MELLITUS; HUMANS; RESPIRATORY FUNCTION TESTS; SPIROMETRY;

EID: 1442299795     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.3.837     Document Type: Editorial

References (17)

1. Goldman MD: Lung dysfunction in diabetes. Diabetes Care 26:1915-1918, 2003
2. Engstrom GM, Janzon L: Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med 19:167-170, 2002
3. Engstrom G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L: Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal study. J Intern Med 253:574-581, 2003
4. Lazarus R, Sparrow D, Weiss ST: Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study. Eur Respir J 12:641-645, 1998
5. Davis WA, Knuiman M, Kendall P, Grange V, Davis TME: Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 27:752-757, 2004
6. Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RML, Rea HH: Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 116:416-423, 1999
7. American Thoracic Society: Standardization of spirometry, 1994 Update. Am J Respir Crit Care Med 152:1107-1136, 1995
8. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Enright PL, Kanner RE, O'Hara P, Owens GR, Scanlon PD, Tashkin DP, Wise RA: Effects of smoking intervention and the use of inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 272:1497-1505, 1994
9. Walter RE, Beiser A, Givelber RJ, O'Connor GT, Gottlieb DJ: Association between glycemic state and lung function: the Framingham Heart Study. Am J Respir Crit Care Med 167:911-916, 2003
10. Niranjan V, McBrayer DG, Ramirez LC, Raskin P, Hsia CC: Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes. Am J Med 103:504-513, 1997
11. Engstrom G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lindgarde F: Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 106:2555-2560, 2002
12. Haffner SM: Insulin resistance, inflammation and the prediabetic state. Am J Cardiol 18:18J-26J, 2003
13. Zanobetti A, Schwartz J: Are diabetics more susceptible to the health effects of airborne particles? Am J Respir Crit Care Med 164:831-833, 2001
14. Stene L, Nafstad P: Relation between occurrence of type I diabetes and asthma. Lancet 357:607-608, 2001
15. Ferguson GT, Enright PL, Buist AS, Higgins MW: Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 117:1146-1161, 2000
16. Lazarus R, Sparrow D, Weiss ST: Hand grip strength and insulin levels: cross-sectional and longitudinal associations in the Normative Aging Study. Metabolism 46:1266-1269, 1997
17. Weiss S: Pulmonary function as a phenotype physiologic marker of cardiovascular morbidity and mortality. Chest 99:265-266, 2001